Interview with Emily Cheah, General Manager, BRASS
Biomedical Research and Support Services Pte Ltd. is an NUS University spin-off that has been around for more than 14 years; last year the company name was changed to BRASS.…
Address: 33 Ubi Avenue 3,
#06-13/14 Vertex,
Singapore 408868.
33 Ubi Avenue 3, #06-13/14 Vertex, Singapore 408868.
33 Ubi Avenue 3, #06-13/14 Vertex, Singapore 408868.
33 Ubi Avenue 3, #06-13/14 Vertex,,Singapore
Tel: +65 6742 6007
Web: http://www.brass-asiapacific.com/c/
BRASS™ was conceived in the National University of Singapore (NUS) on May 1996 with the primary aim of supporting medical device development from concept into reality.
The brainchild of Assoc. Prof. Eugene Khor, BRASS™ is the answer to the biomedical industry’s need for vital infrastructure in support of the medical devices industry. BRASS™ was registered in December 1997 (hence “SINCE 1997”) and in April 1, 1999, the NUS incubation component of BRASS was granted permission to spin-off as a separate entity.
BRASS™ was awarded sole distributorship for the Charles River Endosafe brand of LAL Bacterial Endotoxin Test reagents in Singapore, Indonesia and Malaysia, an achievement that still remains to this day. With its growing success, BRASS™ was able to secure a partnership with the North American Science Associates, Inc. (NAMSA), the world leader in medical device safety evaluation, in July 2002. With this strategic alliance, BRASS™ is able to provide the full panel of GLP ISO 10993 biocompatibility testing, functional and performance studies, and material characterization to the medical device industry as well as gained the rights to distribute the full series of NAMSA Sterilization Assurance Products in several territories in the Asia Pacific region. In 2011, BRASS™ successfully attained representation for Charles River Biopharmaceutical Services in Singapore, Malaysia, Indonesia and Vietnam.
Thirteen years since its humble beginnings, BRASS™ has grown from strength to strength, and counts as its clients various multinational industry leaders, innovative start-ups and research institutes from the pharmaceutical and medical device industry in South East Asia.
Quality Product Provider: broad range of high quality and reliable media, packaging and sterilization assurance products.
Medical Device Expertise
Specialist in Microbiological Testing
Strategic and customized solutions for product development, regulatory compliance and quality assurance throughout the entire life-cycle of the medical device.
Biomedical Research and Support Services Pte Ltd. is an NUS University spin-off that has been around for more than 14 years; last year the company name was changed to BRASS.…
Newly-appointed President & CEO of GE Healthcare ASEAN, Myra Eskes, shares the key lessons of her recent appointment, strategizing according to the diversity of the ASEAN region, and also elaborates…
Recently established in Singapore, Holmusk is a global digital health platform that truly believes in early detection and early intervention. Founder and CEO Nawal Roy describes the underlying motivations behind…
Teva’s recently appointed SVP of APAC and MENA Vivek Bachhawat details his relatively seamless journey from Actavis to Teva and the synergies inherent in both organizations even prior to the…
Siemens Healthineers’ president of Asia Pacific, Elisabeth Staudinger speaks about the company’s redefined strategy—an overarching move from product-centric to value-centric services—and how this ultimately serves to benefit their customers and…
Dedicated Vice-President of APACMed and President of B. Braun’s Asia Pacific operations, Anna Maria Braun, shares the importance of establishing a unifying platform for the industry, the company’s Vision 2020…
Bob White, President, Asia Pacific at Medtronic, explains that transforming healthcare begins first with the patient, particularly in Asia Pacific where there is a rapid evolution of social demographics and…
The CEO of ASLAN Pharmaceuticals, Dr. Carl Firth discusses the implications surrounding the company’s imminent initial public offering on Taiwan’s stock exchange, while explaining how this move serves to position…
As a bio-informatics connoisseur with extensive experience in the pharmaceutical and clinical research field, Human Longevity’s Chief Information Officer, Yaron Turpaz, shares his insights on the company concept, the value…
Biotech CRO InvitroCue Executive director Dr. Steven Fang explains how their technology has disrupted the current clinical trials landscape and the importance of leveraging innovative technologies in meeting future healthcare…
Motivated by the transformative role of big data in healthcare, founder and CEO of Vishuo Biomedical, Dongliang Guo discusses the inspiration behind the company, the successful path to commercialization, as well…
Having recently obtained cGMP from Singapore’s Health Sciences Authority, the founders of PrIME Biologics showcase the role of PrIME Technology in driving plasma self-sufficiency in Asia, while highlighting how this…
Director and senior executive officer of Terumo Corporation and managing director of Terumo Asia Holdings, Hideo Arase recounts key takeaways from working in the US medtech market, the unique M&A…
See our Cookie Privacy Policy Here
